Status:
COMPLETED
Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Dystrophic Epidermolysis Bullosa
Eligibility:
FEMALE
18+ years
Brief Summary
Dystrophic epidermolysis bullosa is a rare genetic pathology resulting in fragility of the skin and mucous membranes, causing bubbles and wounds following trauma. Scarring is pathological with a tende...
Eligibility Criteria
Inclusion
- 18 years old or older
- with hereditary dystrophic epidermolysis bullosa (dominant or recessive)
- followed at the Nice University Hospital or at the St Louis Hospital of the APHP.
- not opposed to participation after being informed of the study
Exclusion
- men
- age \< 18years old
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04757727
Start Date
January 1 2021
End Date
December 30 2021
Last Update
April 3 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de NICE
Nice, France, 06200
2
Hôpital Saint Louis
Paris, France, 75010